N23Ps as a Novel Highly Potent Antifibrotic Therapeutic Compound Class and Discovery of Its Mode of Action in a Human Ex Vivo Fibrosis Model
| Autor: | X. Wei, M. Gerckens, D. Porras-Gonzalez, N.J. Lang, C. Mayr, B. Ballester, H. Ma, F. See, Y. Lin, M. Wögrath, A.-M. Dworsky, F. Pelizza, M.G. Stoleriu, N. Kneidinger, J. Behr, M. Königshoff, O. Eickelberg, M. Lehmann, A.O. Yildirim, O. Plettenburg, H.B. Schiller, G. Burgstaller |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | C17. NOVEL THERAPEUTICS AND BIOMARKERS FOR IDIOPATHIC PULMONARY FIBROSIS. |
| DOI: | 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3721 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|